These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25696931)

  • 1. [Immunoassay of nine serological tumor markers on hydrogel-based microchip].
    Zubcova ZhI; Savvateeva EN; Butvilovskaia VI; Cybul'skaia MV; Chechetkin VR; Samokhina LO; Vinnitskiĭ LI; Maslennikov VV; Reznikov IuP; Zasedatelev AS; Rubina AIu
    Bioorg Khim; 2013; 39(6):693-704. PubMed ID: 25696931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips.
    Butvilovskaya VI; Popletaeva SB; Chechetkin VR; Zubtsova ZI; Tsybulskaya MV; Samokhina LO; Vinnitskii LI; Ragimov AA; Pozharitskaya EI; Grigor Eva GA; Meshalkina NY; Golysheva SV; Shilova NV; Bovin NV; Zasedatelev AS; Rubina AY
    Cancer Med; 2016 Jul; 5(7):1361-72. PubMed ID: 26992329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological microchip for a simultaneous quantitative immunoassay of tumor markers in human serum.
    Savvateeva EN; Dementieva EI; Tsybulskaya MV; Osipova TV; Ryabykh TP; Turygin AY; Yurasov RA; Zasedatelev AS; Rubina AY
    Bull Exp Biol Med; 2009 Jun; 147(6):737-41. PubMed ID: 19902071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of a biochip for quantitative determination of two forms of prostate specific antigen using internal calibration curve].
    Konovalova EV; Savvateeva EN; Dement'eva EI; Filippova MA; Turygin AIu; Osipova TV; Riabykh TP; Rubina AIu; Zasedatelev AS
    Mol Biol (Mosk); 2007; 41(4):734-8. PubMed ID: 17936996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hydrogel microchip as a tool for studying exosomes in human serum].
    Butvilovskaya VI; Tikhonov AA; Savvateeva EN; Ragimov AA; Salimov EL; Voloshin SA; Sidorov DV; Chernichenko MA; Polyakov AP; Filushin MM; Tsybulskaya MV; Rubina AY
    Mol Biol (Mosk); 2017; 51(5):817-823. PubMed ID: 29116068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the probability of cancer with several tumor markers in patients with colorectal disease.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Oncology; 2004; 66(4):296-302. PubMed ID: 15218297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic growth factors in colorectal cancer patients.
    Mroczko B; Szmitkowski M; Okulczyk B
    Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
    Chen C; Chen LQ; Chen LD; Yang GL; Li Y
    Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of antibody functionalized magnetic nanoparticles for the immunoassay of carcinoembryonic antigen: a feasibility study for clinical use.
    Yang CC; Yang SY; Ho CS; Chang JF; Liu BH; Huang KW
    J Nanobiotechnology; 2014 Nov; 12():44. PubMed ID: 25424410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
    Hui L; Rixv L; Xiuying Z
    Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer.
    Louhimo J; Carpelan-Holmström M; Alfthan H; Stenman UH; Järvinen HJ; Haglund C
    Int J Cancer; 2002 Oct; 101(6):545-8. PubMed ID: 12237895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients.
    Mroczko B; Szmitkowski M; Okulczyk B
    Clin Chem Lab Med; 2002 Apr; 40(4):351-5. PubMed ID: 12059074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of multiple tumor markers's protein chip in the screen program of the elderly].
    Yan HY; Zhong RH; Li J; Luo XH; Chen R
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):924-6. PubMed ID: 22340884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.